AMSPARITY Trademark

Trademark Overview

On Friday, June 9, 2017, a trademark application was filed for AMSPARITY with the United States Patent and Trademark Office. The USPTO has given the AMSPARITY trademark a serial number of 87482770. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 26, 2021. This trademark is owned by Pfizer Inc.. The AMSPARITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
amsparity

General Information

Serial Number87482770
Word MarkAMSPARITY
Filing DateFriday, June 9, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 26, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, April 26, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 26, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, September 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 3, 2020EXTENSION 5 GRANTED
Monday, August 24, 2020EXTENSION 5 FILED
Monday, August 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 24, 2020TEAS EXTENSION RECEIVED
Thursday, February 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2020EXTENSION 4 GRANTED
Tuesday, February 4, 2020EXTENSION 4 FILED
Tuesday, February 4, 2020TEAS EXTENSION RECEIVED
Friday, September 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2019EXTENSION 3 GRANTED
Wednesday, September 4, 2019EXTENSION 3 FILED
Wednesday, September 4, 2019TEAS EXTENSION RECEIVED
Saturday, March 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 14, 2019EXTENSION 2 GRANTED
Thursday, March 14, 2019EXTENSION 2 FILED
Thursday, March 14, 2019TEAS EXTENSION RECEIVED
Thursday, September 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 18, 2018EXTENSION 1 GRANTED
Tuesday, September 18, 2018EXTENSION 1 FILED
Tuesday, September 18, 2018TEAS EXTENSION RECEIVED
Tuesday, March 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 28, 2017NON-FINAL ACTION E-MAILED
Monday, August 28, 2017NON-FINAL ACTION WRITTEN
Wednesday, August 23, 2017ASSIGNED TO EXAMINER
Friday, June 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 13, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

amsparity preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases